{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T06:35:21Z","timestamp":1649054121803},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[1990,9,1]],"date-time":"1990-09-01T00:00:00Z","timestamp":652147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gen Intern Med"],"published-print":{"date-parts":[[1990,9]]},"DOI":"10.1007\/bf02600840","type":"journal-article","created":{"date-parts":[[2007,4,5]],"date-time":"2007-04-05T06:38:37Z","timestamp":1175755117000},"page":"S42-S46","source":"Crossref","is-referenced-by-count":1,"title":["Prenatal screening"],"prefix":"10.1007","volume":"5","author":[{"given":"Neil A.","family":"Holtzman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02600840_CR1","volume-title":"Guide to clinical preventive services: an assessment of the effectiveness of 169 interventions","author":"U.S. Preventive Services Task Force","year":"1989","unstructured":"U.S. Preventive Services Task Force. Guide to clinical preventive services: an assessment of the effectiveness of 169 interventions. Baltimore: Williams and Wilkins, 1989."},{"key":"BF02600840_CR2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1056\/NEJM198607313150532","volume":"315","author":"FA Manning","year":"1986","unstructured":"Manning FA, Harrison MR, Rodeck C, et al. Catheter shunts for fetal hydronephrosis and hydrocephalus. N Engl J Med. 1986;315:336\u201340.","journal-title":"N Engl J Med"},{"key":"BF02600840_CR3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(88)92609-8","volume":"2","author":"A Reuss","year":"1988","unstructured":"Reuss A, Wladimiroff JW, Stewart PA, Scholtmeijer RJ. Non-invasive management of fetal obstructive uropathy. Lancet. 1988;2:949\u201350.","journal-title":"Lancet"},{"key":"BF02600840_CR4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(88)90362-5","volume":"1","author":"S Purkiss","year":"1988","unstructured":"Purkiss S, Brereton RJ, Wright VM. Surgical emergencies after prenatal treatment for intra-abdominal abnormality. Lancet. 1988;1:289\u201390.","journal-title":"Lancet"},{"key":"BF02600840_CR5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/0272989X8800800107","volume":"8","author":"TC Li","year":"1988","unstructured":"Li TC, Greenes RA, Weisberg M, Millan D, Flatley M, Goldman L. Data assessing the usefulness of screening obstetrical ultrasonography for detecting fetal and placental abnormalities in uncomplicated pregnancy: effects of screening a low-risk population. Med Decis Making. 1988;8:48\u201354.","journal-title":"Med Decis Making"},{"key":"BF02600840_CR6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/pd.1970080205","volume":"8","author":"DK Manchester","year":"1988","unstructured":"Manchester DK, Pretorius DH, Avery C, et al. Accuracy of ultrasound diagnoses in pregnancies complicated by suspected fetal anomalies. Prenat Diagn. 1988;8:109\u201317.","journal-title":"Prenat Diagn"},{"key":"BF02600840_CR7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0009-9260(88)80002-3","volume":"39","author":"M Gowland","year":"1988","unstructured":"Gowland M. Fetal abnormalities diagnosed from early pregnancy. Clin Radiol. 1988;39:106\u20138.","journal-title":"Clin Radiol"},{"key":"BF02600840_CR8","first-page":"76","volume-title":"Proceed with caution: predicting genetic risks in the recombinant DNA era","author":"NA Holtzman","year":"1989","unstructured":"Holtzman NA. Proceed with caution: predicting genetic risks in the recombinant DNA era. Baltimore: The Johns Hopkins University Press, 1989;76\u201381."},{"key":"BF02600840_CR9","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","volume":"245","author":"B Kerem","year":"1989","unstructured":"Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245:1073\u201380.","journal-title":"Science"},{"key":"BF02600840_CR10","unstructured":"Verlinsky Y, Pergament E, Andresen P, Enriquez G, Strom C. Genetic analysis of polar body DNA: a new approach to preimplantation genetic diagnosis. Am J Hum Genet. 1989;45(suppl)4:A272."},{"key":"BF02600840_CR11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9378(89)80031-6","volume":"160","author":"New England Regional Genetics Group Prenatal Collaborative Study of Down Syndrome Screening","year":"1989","unstructured":"New England Regional Genetics Group Prenatal Collaborative Study of Down Syndrome Screening. Combining maternal serum alpha-fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35. Am J Obstet Gynecol. 1989;160:575\u201380.","journal-title":"Am J Obstet Gynecol"},{"key":"BF02600840_CR12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ajmg.1320310130","volume":"31","author":"M Swint","year":"1988","unstructured":"Swint M, Greenberg F. Maternal serum alpha-fetoprotein screening for Down syndrome: economic considerations. Am J Med Genet. 1988;31:231\u201345.","journal-title":"Am J Med Genet"},{"key":"BF02600840_CR13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00005650-198812000-00008","volume":"26","author":"SH Taplin","year":"1988","unstructured":"Taplin SH, Thompson RS, Conrad DA. Cost-justification analysis of prenatal maternal serum alpha-fetoprotein screening. Med Care. 1988;26:1185\u2013200.","journal-title":"Med Care"},{"key":"BF02600840_CR14","first-page":"203","volume":"71","author":"DS Richards","year":"1988","unstructured":"Richards DS, Seeds JW, Katz VL, Lingley LH, Albright SG, Cefalo RC. Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients. Obstet Gynecol. 1988;71:203\u20137.","journal-title":"Obstet Gynecol"},{"key":"BF02600840_CR15","first-page":"627","volume":"72","author":"A Drugan","year":"1988","unstructured":"Drugan A, Zador IE, Syner FN, Sokol RJ, Sacks AJ, Evans MI. A normal ultrasound does not obviate the need for amniocentesis in patients with elevated serum alpha-fetoprotein. Obstet Gynecol. 1988;72:627\u201330.","journal-title":"Obstet Gynecol"},{"key":"BF02600840_CR16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM198903093201001","volume":"320","author":"GG Rhoads","year":"1989","unstructured":"Rhoads GG, Jackson LG, Schlesselman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med. 1989;320:609\u201317.","journal-title":"N Engl J Med"},{"key":"BF02600840_CR17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/bmj.297.6653.883","volume":"297","author":"NJ Wald","year":"1988","unstructured":"Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum screening for Down\u2019s syndrome in early pregnancy. Br Med J. 1988;297:883\u20137.","journal-title":"Br Med J"},{"key":"BF02600840_CR18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2190\/1YKE-PHP6-H69A-YRKV","volume":"16","author":"R Hubbard","year":"1986","unstructured":"Hubbard R. Eugenics and prenatal testing. Int J Health Serv. 1986;16:227\u201342.","journal-title":"Int J Health Serv"},{"key":"BF02600840_CR19","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2105\/AJPH.75.12.1381","volume":"75","author":"RR Faden","year":"1985","unstructured":"Faden RR, Chwalow AJ, Orel-Crosby E, Holtzman NA, Chase GA, Leonard CO. What participants understand about a maternal serum alpha-fetoprotein screening program. Am J Public Health. 1985;75:1381\u20134.","journal-title":"Am J Public Health"},{"key":"BF02600840_CR20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ajmg.1320310128","volume":"31","author":"L Lustig","year":"1988","unstructured":"Lustig L, Clarke S, Cunningham G, Schonberg R, Tompkinson G. California\u2019s experience with low MS-AFP results. Am J Med Genet. 1988;31:211\u201322.","journal-title":"Am J Med Genet"},{"key":"BF02600840_CR21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/01947648409513403","volume":"5","author":"M Shaw","year":"1984","unstructured":"Shaw M. Conditional prospective rights of the fetus. J Leg Med. 1984;5:63\u2013116.","journal-title":"J Leg Med"},{"key":"BF02600840_CR22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajmg.1320310129","volume":"31","author":"F Greenberg","year":"1988","unstructured":"Greenberg F. The impact of MSAFP screening on genetic services, 1984 \u2013 1986. Am J Med Genet. 1988;31:223\u201330.","journal-title":"Am J Med Genet"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02600840.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02600840\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02600840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T18:33:20Z","timestamp":1558204400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02600840"}},"subtitle":["When and for whom?"],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":22,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[1990,9]]}},"alternative-id":["BF02600840"],"URL":"https:\/\/doi.org\/10.1007\/bf02600840","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,9]]}}}